How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?
Open Access
- 1 January 2013
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 19 (36) , 5964-72
Abstract
In patients with advanced rectal cancer, neoadjuvant chemo radiotherapy provides tumor downstaging and downsizing and complete pathological response in up to 30% of cases. After proctectomy complete pathological response is associated with low rates of local recurrence and excellent long term survival. Several authors claim a less invasive surgery or a non operative policy in patients with partial or clinical complete response respectively, however to identify patients with true complete pathological response before surgical resection remains a challenge. Current imaging techniques have been reported to be highly accurate in the primary staging of rectal cancer, however neoadjuvant therapy course produces deep modifications on cancer tissue and on surrounding structures such as overgrowth fibrosis, deep stroma alteration, wall thickness, muscle disarrangement, tumor necrosis, calcification, and inflammatory infiltration. As a result, the same imaging techniques, when used for restaging, are far less accurate. Local tumor extent may be overestimated or underestimated. The diagnostic accuracy of clinical examination, rectal ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography using 18F-fluoro-2'-deoxy-D-glucose ranges between 25% and 75% being less than 60% in most studies, both for rectal wall invasion and for lymph nodes involvement. In particular the ability to predict complete pathological response, in order to tailor the surgical approach, remains low. Due to the radio-induced tissue modifications, combined with imaging technical aspects, low rate accuracy is achieved, making modern imaging techniques still unreliable in restaging rectal cancer after chemo-radiotherapy.Keywords
This publication has 91 references indexed in Scilit:
- Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancerSurgery, 2011
- The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancerRadiotherapy and Oncology, 2010
- Complete Clinical Response after Neoadjuvant Chemoradiation for Distal Rectal CancerSurgical Oncology Clinics of North America, 2010
- Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation TherapyRadioGraphics, 2010
- Accuracy of MRI and 18F‐FDG PET/CT for Restaging After Preoperative Concurrent Chemoradiotherapy for Rectal CancerWorld Journal of Surgery, 2009
- The Role of Dual-Time Combined 18-Fluorideoxyglucose Positron Emission Tomography and Computed Tomography in the Staging and Restaging Workup of Locally Advanced Rectal Cancer, Treated With Preoperative Chemoradiation Therapy and Radical SurgeryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- La stratégie « attendre et surveiller » chez les patients ayant un cancer du bas rectum avec une réponse clinique complète après radiochimiothérapie néoadjuvanteJournal de Chirurgie, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Endoscopic ultrasound and magnetic resonance imaging forre-staging rectal cancer after radiotherapyWorld Journal of Gastroenterology, 2009
- The value of endorectal ultrasonography in rectal cancer stagingMedicinski Pregled, 2008